Century is seeking FDA authorization for a new product.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Century →

  Japanese company

  Nothing else this week.

Related events

• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• FDA approval is the goal for product candidates from Daré Bioscience, Inc.Jun 7
• A product was launched in the U.S. market following FDA involvement.Sep 8
• Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.Sep 2
• A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.Sep 2